Aspen Aerogels
ASPN
45 hedge funds and large institutions have $78M invested in Aspen Aerogels in 2017 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 12 increasing their positions, 7 reducing their positions, and 5 closing their positions.
71% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 7
20% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 5
8% more capital invested
Capital invested by funds: $72.5M → $78M (+$5.52M)
2% more funds holding
Funds holding: 44 → 45 (+1)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.1% less ownership
Funds ownership: 74.76% → 74.66% (-0.1%)
Top Buyers
Top Sellers
| 1 |
AI
Ariel Investments
Chicago,
Illinois
|
-$1.65M |
| 2 |
MFIMFI
Mesirow Financial Investment Management - Fixed Income
Chicago,
Illinois
|
-$296K |
| 3 |
SIM
Spark Investment Management
New York
|
-$126K |
| 4 |
BlackRock
New York
|
-$97.4K |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$97.3K |
ASPN Hedge Fund Activity: Q2 2017 in Review
45 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Aspen Aerogels (ASPN) for Q2 2017, worth a combined $78M — up 7.6% from $72.5M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new ASPN positions and 5 closed out — a net gain of 1 holder — while 12 added to existing stakes and 7 trimmed.
The largest buyer was Royce & Associates, adding an estimated $726K. The largest seller was Ariel Investments, cutting an estimated $1.65M.
- 45 institutional investors held Aspen Aerogels (ASPN) as of Q2 2017, up from 44 in Q1 2017.
- Funds reported $78M of Aspen Aerogels stock for Q2 2017, up 7.6% quarter-over-quarter.
- 6 funds opened new Aspen Aerogels positions in Q2 2017 and 5 closed out, a net change of +1 holder.
- The largest Aspen Aerogels buyer in Q2 2017 was Royce & Associates, an estimated $726K added.
- The largest Aspen Aerogels seller in Q2 2017 was Ariel Investments, an estimated $1.65M sold.
Based on aggregated 13F filings for Q2 2017.